Abstract:Allergic diseases comprise a genetically heterogeneous cluster of immunologically mediated diseases, including asthma, food allergy (FA), allergic rhinitis (AR) and eczema, that have become major worldwide health problems. Over the past few decades, the spread of allergic diseases has displayed an increasing trend, and it has been reported that 22% of 1.39 billion people in 30 countries have a type of allergic disease. Undoubtedly, allergic diseases, which can be chronic, with significant morbidity, mortality and dynamic progression, impose major economic burdens on society and families; thus, exploring the cause of allergic diseases and reducing their prevalence is a top priority. Recently, it has been reported that the gastrointestinal (GI) microbiota can provide vital signals for the development, function, and regulation of the immune system, and the above-mentioned contributions make the GI microbiota a key player in allergic diseases. Notably, the GI microbiota is highly influenced by the mode of delivery, infant diet, environment, antibiotic use and so on. Specifically, changes in the environment can result in the dysbiosis of the GI microbiota. The proper function of the GI microbiota depends on a stable cellular composition which in the case of the human microbiota consists mainly of bacteria. Large shifts in the ratio between these phyla or the expansion of new bacterial groups lead to a disease-promoting imbalance, which is often referred to as dysbiosis. And the dysbiosis can lead to alterations of the composition of the microbiota and subsequent changes in metabolism. Further, the GI microbiota can affect the physiological characteristics of the human host and modulate the immune response of the host. The objectives of this review are to evaluate the development of the GI microbiota, the main drivers of the colonization of the GI tract, and the potential role of the GI microbiota in allergic diseases and provide a theoretical basis as well as molecular strategies for clinical practice.

The mycobiome in atopic diseases: Inducers and triggers

Pathophysiological Mechanisms of Gut Dysbiosis and Food Allergy and an Investigation of Probiotics as an Intervention for Atopic Disease

Atopic diseases—Diagnostics, mechanisms, and exposures

Biotics in atopic diseases: state of the art and future perspectives

Pathogenesis of Children’s Allergic Diseases: Refocusing the Role of the Gut Microbiota

The role of intestinal bacteria in promoting tolerance to food

Microbiome Composition and Its Impact on the Development of Allergic Diseases

Microbial Dysbiosis Tunes the Immune Response Towards Allergic Disease Outcomes

A pathway linking atopic dermatitis to skin microbes

The “Microflora Hypothesis” of Allergic Disease

Targeting the Gut Microbiome for Atopic Dermatitis: A Comprehensive Review of Mechanisms and Therapeutic Approaches

The skin microbiome in pediatric atopic dermatitis and food allergy

Novel mechanistic insights underlying fungal allergic inflammation

Influence and effect of the human microbiome in allergy and asthma

Update on the pathogenesis of atopic dermatitis

Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans

The Interaction between the Host Genome, Epigenome, and the Gut–Skin Axis Microbiome in Atopic Dermatitis

Respiratory Tract Allergic Disease and Atopy: Experimental Evidence for a Fungal Infectious Etiology

The intestinal barrier as an emerging target in the toxicological assessment of mycotoxins

Microbial intestinal dysbiosis drives long-term allergic susceptibility by sculpting an ILC2-B1 cell-innate IgE axis

Microbe-host interplay in atopic dermatitis and psoriasis